mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |